Relapsing polychondritis, chronic hepatitis C virus infection, and mixed cryoglobulemia

https://doi.org/10.1016/j.semarthrit.2003.11.001Get rights and content

Abstract

Objective

Review of relapsing polychondritis (RP) and its association to chronic hepatitis C virus (HCV) infection and mixed cryoglobulinemia.

Methods

A case of RP associated with HCV infection is reported. The English language medical and scientific literature was reviewed for RP, hepatitis C, and its relation to other connective tissue diseases from February 1966 to January 2003 using MEDLINE.

Results

RP is an uncommon, multisystem disease of unknown etiology characterized by recurrent inflammation of cartilaginous and related tissues, being associated with other diseases in 30% to 35% of cases. HCV infection is a systemic illness with a propensity to trigger or exacerbate autoimmune disorders: eg, essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and leukocytoclastic and systemic vasculitis. We could find no previous report of an association between RP with HCV and mixed cryoglobulinemia. Treatment with interferon gamma and ribavirin (IR) not only induced an undetectable viral load, but also resolved symptoms of RP.

Conclusions

We report a patient with RP, HCV, and mixed cryoglobulinemia. It is unknown if there is a cause-effect or chance relationship. Treatment with IR improved the symptoms of RP. It is not known whether the effects of IR were directly on the RP or suppressed RP indirectly through the actions on the viral load or active hepatitis.

Section snippets

Methods

A case of RP associated with HCV infection is reported. The English language medical literature for RP as well as hepatitis C and cryoglobulinemia associated with polychondritis were reviewed from February 1966 to January 2003 using MEDLINE. Relevant articles published in peer-reviewed journals were analyzed. References of reviewed studies were screened for additional references not apparent from the search. Reviewed studies included those involving history, epidemiology, immunologic mechanisms

Case report

A 74-year-old woman with a medical history of acute myelocytic leukemia 11 years previously was effectively treated and in remission by bone marrow biopsy. One year after the diagnosis of leukemia, she was found to have liver enzymes elevated twice the upper limits of the normal range. Liver biopsy revealed severe portal fibrosis with cholangitis and hemosiderosis. The abnormal liver disease was felt to be the result of leukemia-related multiple blood transfusions. After 10 years, the patient

Epidemiology

The peak age of RP onset is in the fourth and fifth decades, but it has been reported in both extremes of life. The youngest case reported was in a newborn (11), and the oldest was in the ninth decade (12). The annual incidence rate is 3.5 per million. Most authors report an equal gender distribution; however, women develop airway complications more frequently 1, 13, 14. When myelodysplastic syndromes are associated with RP, men predominate (15). All races are affected, with the greatest number

Diagnosis and investigations of RP

The diagnosis of RP is frequently overlooked and delayed because of its low incidence and uncommon symptoms. Several conditions may mimic the clinical presentation, such as infections, allergic reactions, trauma, tumor, and granulomatous diseases. Trentham et al (3) reported a mean delay of 2.9 years from the time that medical attention was sought until diagnosis was established. The delay was longer than 1 year for 68% of patients, and one third of patients presented to 5 or more physicians

Discussion

RP is a rare disease characterized by episodes of inflammation of cartilaginous tissues. HCV infection is more common and often exhibits extrahepatic manifestations, such as mixed cryoglobulinemia. We could find no previous report of RP associated with HCV and mixed cryoglobulinemia. Our patient presented with bilateral auricular chondritis, nasal chondritis, and response to steroids, thus fulfilling the criteria of RP of Damiani and Levine (92). Within 1 year, she also was diagnosed with HCV

Ivonne Herrera, MD: Fellow in Rheumatology and Immunology, Department of Medicine, University of Miami School of Medicine, Miami, Florida

References (141)

  • S.E Nadeau

    Neurologic manifestations of connective tissue disease

    Neurol Clin

    (2002)
  • G.S Firestein et al.

    Mouth and genital ulcers with inflamed cartilageMAGIC syndrome

    Am J Med

    (1985)
  • H Imai et al.

    Mouth and genital ulcers with inflamed cartilage (MAGIC syndrome)A case report and literature review

    Am J Med Sci

    (1997)
  • R Hall et al.

    Relapsing polychondritis, smouldering non-secretory myeloma and early myelodysplastic syndrome in the same patientThree difficult diagnosis produce a life threatening illness

    Leukoc Res

    (2000)
  • J.C Brouet et al.

    Biologic and clinical significance of cryoglobulins. A report of 86 cases

    Am J Med

    (1974)
  • P.D Gorevic et al.

    Mixed cryoglobulinemiaClinical aspects and long-term follow-up of 40 patients

    Am J Med

    (1980)
  • U Specks et al.

    Anticytoplasmic antibodies in the diagnosis and follow-up of Wegener’s granulomatosis

    Mayo Clin Proc

    (1989)
  • B.D Sarodia et al.

    Management of airway manifestations of relapsing polychondritis

    Chest

    (1999)
  • L.P McAdam et al.

    Relapsing polychondritis. Prospective study of 23 patients and a review of the literature

    Medicine

    (1976)
  • C.J Michet et al.

    Relapsing polychondritisSurvival and predictive role of early disease manifestations

    Ann Intern Med

    (1986)
  • D.E Trentham et al.

    Relapsing polychondritis

    Ann Intern Med

    (1998)
  • M Zeuner et al.

    Relapsing polychondritisClinical and immunogenetic analysis of 62 patients

    J Rheumatol

    (1997)
  • F Jacksh-Wartenhorst

    Polychondropathia

    Wien Arch Inn Med

    (1923)
  • M.C Pearson et al.

    Relapsing polycchondritis

    N Engl J Med

    (1960)
  • S.C Gumber et al.

    Hepatitis CA multifaceted disease. Review of extrahepatic manifestations

    Ann Intern Med

    (1995)
  • C Ferri et al.

    Relation between infection and autoimmunity in mixed cryoglobulinemia

    Curr Opin Rheumatol

    (2000)
  • M.H Wener et al.

    Hepatitis C virus and rheumatic disease

    J Rheumatol

    (1996)
  • F.W Arundell et al.

    Familial chronic atrophic polychondritis

    Arch Dermatol

    (1960)
  • M Hebbar et al.

    Association of myelodysplastic syndrome and relapsing polychondritisFurther evidence

    Leukemia

    (1995)
  • T Papo et al.

    Pregnancy in relapsing polychondritisTwenty-five pregnancies in eleven patients

    Arthritis Rheum

    (1997)
  • M.C Boissier et al.

    Arthritogenicity of minor cartilage collagens (types IX and XI) in mice

    Arthritis Rheum

    (1990)
  • D.E Trentham et al.

    Autoimmunity to type II collagenAn experimental model of arthritis

    J Exp Med

    (1977)
  • M.A Cremer et al.

    Type XI collagen—induced arthritis in the Lewis rat. Characterization of cellular and humoral immune responses to native types XI, V, II collagen and constituent α-chains

    J Immunol

    (1994)
  • S Alsalemeh et al.

    Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis

    J Rheumatol

    (1993)
  • J.M Foidart et al.

    Antibodies to type II collagen in relapsing polychondritis

    N Engl J Med

    (1978)
  • K Terato et al.

    Specificity of antibodies to type II collagen in rheumatoid arthritis

    Arthritis Rheum

    (1990)
  • A.D Cook et al.

    Antibodies to type II collagen in early rheumatoid arthritisCorrelation with disease progression

    Arthritis Rheum

    (1996)
  • R.B Clague et al.

    The prevalence of serum IgG antibodies to type II collagen in American patients with rheumatoid arthritis

    Br J Rheumtol

    (1994)
  • A.S Hansson et al.

    The occurrence of autoantibodies to matriline 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis

    Arthritis Rheum

    (2001)
  • J.H Buckner et al.

    Autoreactivity against matrilin-1 in a patient with relapsing polychondritis

    Arthritis Rheum

    (2000)
  • A.S Hansson et al.

    A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1)

    J Clin Inves

    (1999)
  • W.J Issing et al.

    Anti-labyrinthine antibodies in a patient with relapsing polychondritis

    Eur Arch Otorhinolaryngol

    (1999)
  • D.L Dolan et al.

    Relapsing polychondritis. Analytical literature review and studies on pathogenesis

    Am J Med

    (1966)
  • C.L Yang et al.

    Autoantibodies to cartilage collagens in relapsing polychondritis

    Arch Dermatol Res

    (1993)
  • R Ohwatari et al.

    Serum level of macrophage migration inhibitory factor as a useful paramenter of clinical course in patients with Wegener’s granulomatosis and relapsing polychondritis

    Ann Otol Rhinol Laryngol

    (2001)
  • A Mikulowska et al.

    Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice

    J Immunol

    (1997)
  • B Lang et al.

    Susceptibility to relapsing polychondritis is associated with HLA-DR4

    Arthritis Rheum

    (1993)
  • E Diaz-Jouanen et al.

    Chondritis of the ear in Wegener’s granulomatosis

    Arthritis Rheum

    (1977)
  • T.V McCaffrey et al.

    Head and neck manifestations of relapsing polychondritisreview of 29 cases

    Otolaryngology

    (1978)
  • H.S Luthra

    Relapsing polychondritis

  • Cited by (17)

    • Extrahepatic Manifestations in Patients With Chronic Hepatitis C Virus Infection

      2017, Handbook of Systemic Autoimmune Diseases
      Citation Excerpt :

      Other SAD associated with HCV have been reported, including Behcet disease (seven cases), Still disease (one case), ankylosing spondylitis (one case), and mixed connective tissue disease (one case) [5]. Herrera et al. [93] reported a patient with relapsing polychondritis (RP), HCV, and MC, in whom treatment with anti-HCV therapy improved the symptoms of RP. The specific tropism of HCV for many extrahepatic cell types (Table 9.5), especially for circulating blood cells, has been suggested by several studies [40,41,94–103], providing a clear link between HCV and the development of autoimmune and neoplastic hematological processes.

    • Cholestasis as the initial presentation of relapsing polychondritis

      2011, Annals of Hepatology
      Citation Excerpt :

      In addition, this report antedated the discovery of hepatitis C virus, recognized over the last few years as a significant cause of liver disease worldwide.7 In fact, more recently, the association between RPC, chronic hepatitis C virus infection and mixed cryog-lobulemia was reported.8 In this case, a 74-year-old woman presented with RPC-related symptoms several months before the diagnosis of hepatitis C and mixed cryoglobulinemia syndrome.

    • Chapter 16 Extrahepatic Manifestations in Patients with Chronic Hepatitis C Virus Infection

      2008, Handbook of Systemic Autoimmune Diseases
      Citation Excerpt :

      Other SAD associated with HCV have been reported, including Behçet disease (seven cases), Still disease (one case), ankylosing spondylitis (one case), and mixed connective tissue disease (one case) (Ramos-Casals et al., 2005d). Herrera et al. (2004) reported a patient with relapsing polychondritis (RP), HCV, and MC, in whom treatment with anti-HCV therapy improved the symptoms of RP. The specific tropism of HCV for many extrahepatic cell types (Table 5), especially for circulating blood cells, has recently been suggested by several studies (Arrieta et al., 2001; Toussirot et al., 2002; Crovatto et al., 2000; De Almeida et al., 2004; De Vita et al., 2000; Authier et al., 2003; Di Muzio et al., 2003; Bonetti et al., 1999; Radkowski et al., 2002; Okabe et al., 1997; Agnello and Abel, 1997; Ducoulombier et al., 2004), providing a clear link between HCV and the development of autoimmune and neoplasic hematological processes.

    View all citing articles on Scopus

    Ivonne Herrera, MD: Fellow in Rheumatology and Immunology, Department of Medicine, University of Miami School of Medicine, Miami, Florida

    Ronald Concha, MD: Resident in Internal Medicine, Department of Medicine, University of Miami School of Medicine, Miami, Florida

    Enrique G. Molina, MD: Assistant Professor of Medicine, Center for Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida

    Eugene R. Schiff, MD: Professor of Medicine and Chief, Division of Hepatology Center for Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida

    Roy D. Altman, MD: Clinical Director, GRECC, Miami VAMC, Professor of Medicine and Chief, Rheumatology and Immunology, Department of Medicine, University of Miami School of Medicine, Miami, Florida.

    View full text